Literature DB >> 7678227

Role of flanking variable sequences in antigenicity of consensus regions of HIV gp120 for recognition by specific human T helper clones.

F Manca1, J A Habeshaw, A G Dalgleish, D Fenoglio, G Li Pira, E E Sercarz.   

Abstract

Human T helper cells can discriminate among strain variants of HIV gp120 because of T cell clones recognizing non-conserved regions, as demonstrated with T cells from HIV-infected individuals and vaccinated volunteers and with primary T cell lines and clones obtained by in vitro immunization. To obtain a better definition of cross-reactions among T cell determinants within HIV gp120 variants, we used a panel of analog peptides within residues 236-251 from the BRU, MN, SF2 and RF strain sequences to induce primary human T cell lines and clones. Different patterns of response were obtained using each of the analog peptides, although they all share the consensus sequence 246-251. Clones recognizing this sequence were generated by priming with the BRU and RF analog peptides, but not with the SF2 analog peptide. SF2 did not induce any 242-245-specific clones, but only T cells recognizing the 236-240 sequence. A preferential response to residues 236-240 was obtained by priming with the BRU and SF2 peptides, but not with the MN and RF peptides. These results suggest that although the analog peptides exhibit a high degree of homology and share a consensus of the C-terminal sequence (246-251), the T cell response to the conserved sequence 246-251 is controlled by flanking sequences. Therefore the presence of a shared sequence per se does not imply in vitro expansion of clones with that fine specificity, even though such clones are available within the naive repertoire and can be triggered by an analog peptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678227     DOI: 10.1002/eji.1830230142

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.

Authors:  G Girolomoni; M T Valle; V Zacchi; M G Costa; A Giannetti; F Manca
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.

Authors:  M H Fernandez; A Faith; J A Higgins; J Weber; A D Rees
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

3.  Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85.

Authors:  M T Valle; A M Megiovanni; A Merlo; G Li Pira; L Bottone; G Angelini; L Bracci; L Lozzi; K Huygen; F Manca
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.

Authors:  S Peifang; G L Pira; D Fenoglio; S Harris; M G Costa; V Venturino; V Dessì; G Layton; J Laman; J G Huisman
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

5.  Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence.

Authors:  J D Ahlers; T Takeshita; C D Pendleton; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.

Authors:  C Lekutis; N L Letvin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  The influence of MHC polymorphism on the selection of T-cell determinants of FMDV in cattle.

Authors:  M J Van Lierop; P R Nilsson; J P Wagenaar; J M Van Noort; J D Campbell; E J Glass; I Joosten; E J Hensen
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

8.  H-2-associated effects of flanking residues on the recognition of a permissive mycobacterial T-cell epitope.

Authors:  E Román; D P Harris; S Jurcevic; J Ivanyi; C Moreno
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.